Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-25

Clinical Trial Update: Special Drug Use Investigation for LAMICTAL Bipolar

View source ↗

Summary

A Special Drug Use Investigation for Lamictal (lamotrigine) in bipolar disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LAMICTAL (LAMOTRIGINE)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Bipolar Disorder | Status: COMPLETED